INM Competitors & Alternatives

Compare InMed Pharmaceuticals Inc with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

INM

Main Stock
$1.59
Tradestie Score
56
Market Cap
$5.29M
Revenue Growth
-0.3%
Analyst Upside
+1157.9%

Top Competitors

47 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
CRON Cronos Group Inc. Common Share
$2.71
$1.02B - 59 Compare
ESPR Esperion Therapeutics, Inc.
$3.14
$584.71M - 61 Compare
ETON Eton Pharmaceutcials, Inc. Common Stock
$27.61
$543.32M - 48 Compare
IRWD Ironwood Pharmaceuticals, Inc. - Class A
$3.24
$237.15M 5.3 52 Compare
BIOA BioAge Labs, Inc. Common Stock
$16.04
$212.23M - 56 Compare
ENSC Ensysce Biosciences, Inc. Common Stock
$0.27
$7.21M - 51 Compare
QNRX Quoin Pharmaceuticals, Ltd. American Depositary Shares
$4.43
$4.25M - 45 Compare
REVB Revelation Biosciences, Inc. Common Stock
$1.04
$3.42M - 46 Compare
NUWE Nuwellis, Inc. Common Stock
$0.49
$2.90M - 41 Compare
VRAX Virax Biolabs Group Limited Ordinary Shares
$0.24
$2.69M - 50 Compare

Data updated: Jun 03, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

47 stocks in this industry